Ovid Therapeutics (1OT.F) Q4 2024 Earnings

Nov 12Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.21
-0.1
0
0.11

Details

Expected EPS
-0.19453999154999999
Actual EPS
-0.18839
Surprise EPS
0.01
Surprise Percent
+3.16%

Description

⁨Ovid Therapeutics⁩ (⁦1OT.F⁩) has reported earnings of ⁦-0.18839⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts